Cargando…
Polygenic risk of type 2 diabetes is associated with incident vascular dementia: a prospective cohort study
Type 2 diabetes and dementia are associated, but it is unclear whether the two diseases have common genetic risk markers that could partly explain their association. It is also unclear whether the association between the two diseases is of a causal nature. Furthermore, few studies on diabetes and de...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118265/ https://www.ncbi.nlm.nih.gov/pubmed/37091584 http://dx.doi.org/10.1093/braincomms/fcad054 |
_version_ | 1785028772061249536 |
---|---|
author | Dybjer, Elin Kumar, Atul Nägga, Katarina Engström, Gunnar Mattsson-Carlgren, Niklas Nilsson, Peter M Melander, Olle Hansson, Oskar |
author_facet | Dybjer, Elin Kumar, Atul Nägga, Katarina Engström, Gunnar Mattsson-Carlgren, Niklas Nilsson, Peter M Melander, Olle Hansson, Oskar |
author_sort | Dybjer, Elin |
collection | PubMed |
description | Type 2 diabetes and dementia are associated, but it is unclear whether the two diseases have common genetic risk markers that could partly explain their association. It is also unclear whether the association between the two diseases is of a causal nature. Furthermore, few studies on diabetes and dementia have validated dementia end-points with high diagnostic precision. We tested associations between polygenic risk scores for type 2 diabetes, fasting glucose, fasting insulin and haemoglobin A(1c) as exposure variables and dementia as outcome variables in 29 139 adults (mean age 55) followed for 20–23 years. Dementia diagnoses were validated by physicians through data from medical records, neuroimaging and biomarkers in cerebrospinal fluid. The dementia end-points included all-cause dementia, mixed dementia, Alzheimer’s disease and vascular dementia. We also tested causal associations between type 2 diabetes and dementia through two-sample Mendelian randomization analyses. Seven different polygenic risk scores including single-nucleotide polymorphisms with different significance thresholds for type 2 diabetes were tested. A polygenic risk score including 4891 single-nucleotide polymorphisms with a P-value of <5e-04 showed the strongest association with different outcomes, including all-cause dementia (hazard ratio 1.11; Bonferroni corrected P = 3.6e-03), mixed dementia (hazard ratio 1.18; Bonferroni corrected P = 3.3e-04) and vascular dementia cases (hazard ratio 1.28; Bonferroni corrected P = 9.6e-05). The associations were stronger for non-carriers of the Alzheimer’s disease risk gene APOE ε4. There was, however, no significant association between polygenic risk scores for type 2 diabetes and Alzheimer’s disease. Furthermore, two-sample Mendelian randomization analyses could not confirm a causal link between genetic risk markers of type 2 diabetes and dementia outcomes. In conclusion, polygenic risk of type 2 diabetes is associated with an increased risk of dementia, in particular vascular dementia. The findings imply that certain people with type 2 diabetes may, due to their genetic background, be more prone to develop diabetes-associated dementia. This knowledge could in the future lead to targeted preventive strategies in clinical practice. |
format | Online Article Text |
id | pubmed-10118265 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-101182652023-04-21 Polygenic risk of type 2 diabetes is associated with incident vascular dementia: a prospective cohort study Dybjer, Elin Kumar, Atul Nägga, Katarina Engström, Gunnar Mattsson-Carlgren, Niklas Nilsson, Peter M Melander, Olle Hansson, Oskar Brain Commun Original Article Type 2 diabetes and dementia are associated, but it is unclear whether the two diseases have common genetic risk markers that could partly explain their association. It is also unclear whether the association between the two diseases is of a causal nature. Furthermore, few studies on diabetes and dementia have validated dementia end-points with high diagnostic precision. We tested associations between polygenic risk scores for type 2 diabetes, fasting glucose, fasting insulin and haemoglobin A(1c) as exposure variables and dementia as outcome variables in 29 139 adults (mean age 55) followed for 20–23 years. Dementia diagnoses were validated by physicians through data from medical records, neuroimaging and biomarkers in cerebrospinal fluid. The dementia end-points included all-cause dementia, mixed dementia, Alzheimer’s disease and vascular dementia. We also tested causal associations between type 2 diabetes and dementia through two-sample Mendelian randomization analyses. Seven different polygenic risk scores including single-nucleotide polymorphisms with different significance thresholds for type 2 diabetes were tested. A polygenic risk score including 4891 single-nucleotide polymorphisms with a P-value of <5e-04 showed the strongest association with different outcomes, including all-cause dementia (hazard ratio 1.11; Bonferroni corrected P = 3.6e-03), mixed dementia (hazard ratio 1.18; Bonferroni corrected P = 3.3e-04) and vascular dementia cases (hazard ratio 1.28; Bonferroni corrected P = 9.6e-05). The associations were stronger for non-carriers of the Alzheimer’s disease risk gene APOE ε4. There was, however, no significant association between polygenic risk scores for type 2 diabetes and Alzheimer’s disease. Furthermore, two-sample Mendelian randomization analyses could not confirm a causal link between genetic risk markers of type 2 diabetes and dementia outcomes. In conclusion, polygenic risk of type 2 diabetes is associated with an increased risk of dementia, in particular vascular dementia. The findings imply that certain people with type 2 diabetes may, due to their genetic background, be more prone to develop diabetes-associated dementia. This knowledge could in the future lead to targeted preventive strategies in clinical practice. Oxford University Press 2023-03-06 /pmc/articles/PMC10118265/ /pubmed/37091584 http://dx.doi.org/10.1093/braincomms/fcad054 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Dybjer, Elin Kumar, Atul Nägga, Katarina Engström, Gunnar Mattsson-Carlgren, Niklas Nilsson, Peter M Melander, Olle Hansson, Oskar Polygenic risk of type 2 diabetes is associated with incident vascular dementia: a prospective cohort study |
title | Polygenic risk of type 2 diabetes is associated with incident vascular dementia: a prospective cohort study |
title_full | Polygenic risk of type 2 diabetes is associated with incident vascular dementia: a prospective cohort study |
title_fullStr | Polygenic risk of type 2 diabetes is associated with incident vascular dementia: a prospective cohort study |
title_full_unstemmed | Polygenic risk of type 2 diabetes is associated with incident vascular dementia: a prospective cohort study |
title_short | Polygenic risk of type 2 diabetes is associated with incident vascular dementia: a prospective cohort study |
title_sort | polygenic risk of type 2 diabetes is associated with incident vascular dementia: a prospective cohort study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118265/ https://www.ncbi.nlm.nih.gov/pubmed/37091584 http://dx.doi.org/10.1093/braincomms/fcad054 |
work_keys_str_mv | AT dybjerelin polygenicriskoftype2diabetesisassociatedwithincidentvasculardementiaaprospectivecohortstudy AT kumaratul polygenicriskoftype2diabetesisassociatedwithincidentvasculardementiaaprospectivecohortstudy AT naggakatarina polygenicriskoftype2diabetesisassociatedwithincidentvasculardementiaaprospectivecohortstudy AT engstromgunnar polygenicriskoftype2diabetesisassociatedwithincidentvasculardementiaaprospectivecohortstudy AT mattssoncarlgrenniklas polygenicriskoftype2diabetesisassociatedwithincidentvasculardementiaaprospectivecohortstudy AT nilssonpeterm polygenicriskoftype2diabetesisassociatedwithincidentvasculardementiaaprospectivecohortstudy AT melanderolle polygenicriskoftype2diabetesisassociatedwithincidentvasculardementiaaprospectivecohortstudy AT hanssonoskar polygenicriskoftype2diabetesisassociatedwithincidentvasculardementiaaprospectivecohortstudy |